Healthcare Distribution Alliance – Patients Move Us.
Share Print



Results: 53 Articles found.
  • HDA Statement on FDA Authorization of First COVID-19 Vaccine
    December 11, 2020

    HDA President and CEO Chester “Chip” Davis, Jr., released the following statement on the U.S. Food and Drug Administration’s (FDA) decision to grant Emergency Use Authorization of the first COVID-19 vaccine, manufactured by Pfizer and BioNTech.

  • HDA Research Foundation Quantifies Efficiencies Provided by Specialty Rx Distributors
    December 10, 2020

    New data released today by the HDA Research Foundation illustrate the continued supply chain efficiencies generated by HDA-member specialty distributors. According to the latest edition of Specialty Pharmaceutical Distribution: Facts, Figures and Trends, specialty distributors are a vital nexus between 176 manufacturers and more than 49,000 provider ship-to points for administration or dispensing to patients.

  • AAOA, NHMA Release Bilingual Toolkit Focused on Prescription Opioid Safety and Pain Management
    December 8, 2020

    Allied Against Opioid Abuse (AAOA) and the National Hispanic Medical Association (NHMA) released a new suite of resources to help educate the Hispanic community about the rights, risks and responsibilities associated with prescription opioids. The toolkit was developed by an advisory committee of NHMA members and features resources available in both Spanish and English.

  • HDA Pharmaceutical Distributors Manage 93 Percent of 2019 U.S. Sales
    December 3, 2020

    Data published today by the HDA Research Foundation reveal an estimated 93 percent of all U.S. pharmaceutical sales were completed through HDA-member traditional pharmaceutical distributors in 2019. As illustrated in the 91st Edition HDA Factbook, total distributor sales reached $519 billion.

  • HDA Statement on Drug Affordability Policies
    November 23, 2020

    HDA President and CEO Chester “Chip” Davis, Jr., released the following statement on the announcement by the Department of Health and Human Services (HHS) of an interim final rule to implement a “Most Favored Nation Model” for Medicare Part B and a final rule eliminating the prescription drug rebate system for Medicare Part D.

Media Contacts

John Parker
(703) 885-0216

Elyse Petroni
(703) 885-0221

Farah Simonett
(703) 885-0269

© 2020 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365